Study of Efficacy of Spinal Cord DTM Stimulation via a Paddle-type Lead for Neuropathic Pain Following a Spinal Cord Lesion

Saito Ryuta0 sites10 target enrollmentNovember 21, 2022

Overview

No summary available.

Registry

who.int

Start Date

November 21, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Saito Ryuta

•Patients with intractable neuropathic pain following spinal cord lesion resistance to medication treatments
•\-18 years of age or older
•\-Pain scale of VAS (Visual analog scale) is more than 4 point
•\-Patients who classified as Frankel grade: B\-E
•\-Patients in whom a paddle\-shaped lead can be placed on the rostral side of the spinal cord lesion
•\-Patients who have obtained written consent from the patient

•\-Patients for whom local and general anesthesia cannot be performed
•\-Patients who classified as Frankel grade A
•\-Patients receiving anti\-cancer therapy
•\-Patients with a history of drug abuse
•\-Patients with high risk of surgery, such as patients with unstable angina pectoris and with end\-stage liver disease presenting with hepatic encephalopathy
•\-Patients with diabetes mellitus who are not well controlled (HbA1c 9% or more)
•\-Patients with serious complications (liver disease, kidney disease, heart disease, lung disease, blood disease, brain disease, etc.)
•\-Pregnant or potentially pregnant patients
•\-Patients who are considered as inappropriate by a head of research or research assignations